Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

Clinical trial NCT05664815 · RECRUITING

Trial details

NCT number: NCT05664815
Sponsor: Centre Hospitalier Universitaire de Besancon
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Osteonecrosis Due to Drugs, Jaw

Start date: 2023-09-22
Primary completion: 2025-09-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.